Assay News and Research

RSS
A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Using CRISPR/Cas to develop biosafety materials

Using CRISPR/Cas to develop biosafety materials

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

New test greatly simplifies the diagnosis of allergies

New test greatly simplifies the diagnosis of allergies

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Safety and antibody responses to COVID-19 vaccines in an older community

Safety and antibody responses to COVID-19 vaccines in an older community

Neutralizing antibody responses against parental SARS-CoV-2 strain as well as against Omicron BA.1 and BA.2 variants

Neutralizing antibody responses against parental SARS-CoV-2 strain as well as against Omicron BA.1 and BA.2 variants

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Response to COVID-19 boosters in seronegative multiple sclerosis patients

How does the non-structural protein 1 affect COVID-19 pathogenicity?

How does the non-structural protein 1 affect COVID-19 pathogenicity?

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

Why does the SARS-CoV-2 Omicron variant escape immunity?

Why does the SARS-CoV-2 Omicron variant escape immunity?

Novel screening method detects new N501T SARS-CoV-2 variant

Novel screening method detects new N501T SARS-CoV-2 variant

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

Evaluating vesicular stomatitis virus-based COVID-19 vaccines against SARS-CoV-2 variants in hamsters

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.